Augestadt et al. [36] conducted a qualitative study with women newly diagnosed with BC or OC who were consecutively offered testing for BRCA1 and BRCA2 pathogenic variants at the time of cancer diagnosis without receiving genetic counselling prior to genetic testing. The gene discussed is BRCA2; the disease is breast cancer.